Predictive Oncology Inc.
POAI
$6.00
$0.458.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2,409.19% | 34.92% | 42.09% | 37.57% | -- |
| Total Depreciation and Amortization | 10.37% | 9.66% | 8.92% | 10.75% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22,046.08% | -236.81% | 844.23% | -106.38% | -- |
| Change in Net Operating Assets | 264.89% | -47.94% | 61.38% | -56.31% | -- |
| Cash from Operations | 47.88% | -3.28% | 77.86% | 30.30% | -2.19% |
| Capital Expenditure | -- | -- | -- | -100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 100.00% | -- | 100.00% | -- |
| Cash from Investing | -100.00% | 100.00% | 20,933.33% | -100.00% | 920.51% |
| Total Debt Issued | -- | -4.03% | -- | -- | -- |
| Total Debt Repaid | 3.28% | -- | -- | -78.32% | -- |
| Issuance of Common Stock | 14.18% | -84.14% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.18% | 78.55% | -- | -- | -- |
| Cash from Financing | 49.65% | -78.36% | 2,323.93% | -75.92% | 241.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.60% | -2,030.78% | 167.06% | 26.43% | 20.92% |